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Microorganisms of the Enterobacteriaceae family are
among the most widespread pathogens of infectious dis-
eases including hospital infections. Beta-lactam antibi-
otics, which at the present time make up more than half
of antibiotics used in the world, are applied as antibacter-
ial drugs for treatment of these diseases. However, more
and more frequent cases of clinical inefficiency of drug
therapy by this group of antibiotics appear due to devel-
opment of drug resistance among the microorganisms.
This biological phenomenon is called “antibiotic resist-
ance”. The problem of bacterial resistance to antimicro-
bial preparations emerged practically simultaneously with
the beginning of use of antibiotics in the 1940s. Already a
year after the beginning of the use of penicillin, an
enzyme destroying this antibiotic, penicillinase, was
detected in Staphylococcus aureus. Data concerning
microorganisms resistant to certain antibiotic groups
appeared in the 1970s, while already at the end of that
century microbial strains resistant to all known antibiotics
were described. Thus, the study of problems associated
with resistance to antibiotics as well as searching for ways
of addressing these problems became prominent for the
world.
The main mechanism of emergence of resistance of
the Enterobacteriaceae family to beta-lactam antibiotics is
the appearance in their genes of chance mutations able to
change the spectrum of bacterial enzyme activities.
Bacterial enzymes able to cleave beta-lactam antibiotics
are known as beta-lactamases. Beta-lactamases comprise
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Abstract—More than half of all currently used antibiotics belong to the beta-lactam group, but their clinical effectiveness is
severely limited by antibiotic resistance of microorganisms that are the causative agents of infectious diseases. Several mech-
anisms for the resistance of Enterobacteriaceae have been established, but the main one is the enzymatic hydrolysis of the
antibiotic by specific enzymes called beta-lactamases. Beta-lactamases represent a large group of genetically and function-
ally different enzymes of which extended-spectrum beta-lactamases (ESBLs) pose the greatest threat. Due to the plasmid
localization of the encoded genes, the distribution of these enzymes among the pathogens increases every year. Among
ESBLs the most widespread and clinically relevant are class A ESBLs of TEM, SHV, and CTX-M types. TEM and SHV
type ESBLs are derived from penicillinases TEM-1, TEM-2, and SHV-1 and are characterized by several single amino acid
substitutions. The extended spectrum of substrate specificity for CTX-M beta-lactamases is also associated with the emer-
gence of single mutations in the coding genes. The present review describes various molecular-biological methods used to
identify determinants of antibiotic resistance. Particular attention is given to the method of hybridization analysis on
microarrays, which allows simultaneous multiparametric determination of many genes and point mutations in them. A sep-
arate chapter deals with the use of hybridization analysis on microarrays for genotyping of the major clinically significant
ESBLs. Specificity of mutation detection by means of hybridization analysis with different detection techniques is com-
pared.
DOI: 10.1134/S0006297910130080
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a superfamily of genetically and functionally different
enzymes joined by the ability to destroy the beta-lactam
ring, which results in the loss by the antibiotic of its
antimicrobial activity. Gram-negative bacteria of the
Enterobacteriaceae family that are resistant to the third
generation of cephalosporins are now the main problem
in clinical practice. They produce the so-called extended
spectrum beta-lactamases (ESBL) [1]. The first ESBLs,
derivatives of the broad spectrum beta-lactamases, were
discovered in the mid 1980s. Now over 300 such enzymes
are described, and the number is constantly increasing.
ESBLs have been detected in all members of the
Enterobacteriaceae family as well as in Pseudomonas
aeruginosa and Acinetobacter baumannii. In most cases
the ESBL genes are localized on plasmids, and this is the
reason for extremely rapid spreading of resistant
pathogens all over the world [2, 3]. This makes difficult
correct diagnosis and choice of an adequate method of
treatment, which increases the number of cases of ineffi-
cient therapy, lengthening and increasing the cost of ther-
apy [4, 5]. Thus, the need for efficient laboratory diagno-
sis of ESBL production by Gram-negative microorgan-
isms is obvious. The difficulty of detection of beta-lacta-
mase in routine practice should be considered as an
important feature of these enzymes. Standard clinical
methods of determination of the nature of pathogens
causing infectious diseases and revealing their resistance
to antibiotics are based on phenotypic characteristics of
microbial pathogens. At best, these methods of ESBL
detection make it possible to determine that the enzyme
is present, but they cannot give information about any
particular enzyme. Besides, it is difficult to use these
methods in analysis of simultaneous multiple resistance
to several groups of antibiotics, whereas the number of
such cases is increasing.
The geographical diffusion of β-lactamases and
emergence of multiple resistances make necessary simul-
taneous determination of several genes and their muta-
tions, i.e. multiparametric analysis. Molecular-biological
methods for gene analysis are useful for solution of this
kind of problem. Investigations in chemistry and bio-
chemistry of nucleic acids during last decades not only
resulted in revolutionary advances in biology, but they
exerted a pronounced effect on development of new
methods in biotechnology and gene engineering, includ-
ing technologies that can be applied for multiparametric
analysis of gene structure and detection of point muta-
tions at the molecular level. Recently several reviews have
been published that deal with the resistance of microor-
ganisms to beta-lactam antibiotics and the spreading and
properties of beta-lactamase family enzymes [6-9].
However, there are no reviews concerning molecular-bio-
logical methods for detection of beta-lactamases enabling
simultaneous detection of several antibiotic resistance
determinants. The goal of this review was to generalize all
available data in this field. Separate sections deal with
methods for multiparametric hybridization analysis for
detection of several antibiotic resistance determinants
and ESBL identification.
ANTIBIOTIC RESISTANCE
CAUSED BY BETA-LACTAMASES
The term “antibiotic resistance” characterizes resist-
ance of bacterial pathogens of infectious diseases to
antibiotics and is a particular case of a more common
event of “antimicrobial resistance”, resistance of
pathogens of different nature infectious (bacteria, viruses,
protozoa) to drug preparations. One of the most widely
used classes of antibiotics is beta-lactam antibiotics (beta-
lactams). Beta-lactams are polar hydrophilic compounds
penetrating into bacterial cells through porin channels of
the outer membrane [10]. Beta-lactams are divided into
several groups based on their chemical structures having a
beta-lactam ring as the component in common (Table 1).
Cephalosporins are most often used for treatment of
infections caused by Gram-positive and Gram-negative
bacteria. Antibiotics of the penicillin group are most often
used for treatment of infections caused by Gram-positive
microbial pathogens. The use of carbapenems as wide
spectrum antibiotics has recently increased.
The action mechanism of beta-lactam includes
binding to penicillin-binding proteins (PBP) – trans- and
carboxypeptidases involved in formation of peptidoglycan
chains of the inner bacterial membrane. The interaction
of PBP with beta-lactam antibiotics results in disturbance
of peptidoglycan synthesis, cessation of cell division, and
cell death. The binding of the antibiotic to PBP is based
on the affinity of the beta-lactam structure to that of the
PBP active site. Owing to this, the presence of a beta-lac-
tam ring is necessary for the antibacterial activity of the
antibiotic. Upon the interaction of the beta-lactam with
PBP, an acyl-enzyme complex is formed and the C–N
bond in the four-membered cycle of the beta-lactam ring
is broken.
Point mutations emerged during evolution of some
PBP, which resulted in appearance of beta-lactamases
able to hydrolyze the lactam ring of antibiotics.
Comparative analysis of all PBP and beta-lactamase
sequences supports a hypothesis concerning the existence
of a common precursor of these proteins [11].
The following mechanisms of emergence of bacteri-
al resistance to beta-lactam antibiotics have been
revealed: (i) synthesis of beta-lactamases destroying these
antibiotics [11-13]; (ii) lowering the bacterial outer mem-
brane permeability due to the loss of or decrease in porin
expression [14]; (iii) change in PBP structure [15]; (iv)
active antibiotic extrusion from the microbial cell (efflux
system) [16, 17]. Beta-lactamase synthesis is considered
as the main mechanism providing resistance of clinically
important strains of Gram-negative bacteria to beta-lac-
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tam antibiotics [6, 18, 19]. Genetic mutations resulting in
replacement of just a few amino acids in a protein
sequence alter the enzyme structure resulting in signifi-
cant broadening of the antibiotic spectrum subjected to
hydrolysis [20, 21]. Mutations can emerge rather quickly;
there are cases when microorganisms became resistant to
antibiotics during the course of treatment.
Resistance can be inborn or acquired. The real natu-
ral resistance is characterized by the absence from
microorganisms of a target for revealing antibiotic activity.
Some microorganisms are able to produce chromosome-
encoded beta-lactamases, for example, Klebsiella pneumo-
niae produces beta-lactamase SHV-1 and Enterobacter
cloacae, Enterobacter aerogenes, Citrobacter freundii,
Serrata spp., and Pseudomonas aeruginosa produce C class
beta-lactamases. The ability of individual bacterial strains
to retain viability at antibiotic concentrations inhibiting
the bulk of the microbial population is considered as
acquired or secondary resistance. Situations are possible
when most of the population exhibits the acquired resist-
ance. Formation of acquired resistance is always due to
acquiring of new genetic information or to alteration of
the native gene expression level. Most often secondary
resistance determinants are acquired together with mobile
genetic elements. The resistance of Enterobacteriaceae
family members to beta-lactam antibiotics is acquired
resistance. The ESBL genes are transferred by different
mobile genetic elements like plasmids, transposons, IS-
elements, class 1 integrons, and the ISCR1 element con-
taining integrons [22, 23]. The variety of mechanisms of
genetic transfer contributes to rapid spreading of these
genes. From the point of view of diagnosis, just detection
of emergence and transfer of acquired resistance compris-
es the main problem because it is impossible to forecast its
presence in the infectious pathogen.
Classification of Beta-Lactamases
Over 500 different beta-lactamases have been
described, and this number is rapidly increasing each
year. This enzyme family itself can be called a superfami-
ly because it joins several huge groups or subfamilies dif-
fering in enzymatic properties. They are united on the
basis of their ability to hydrolyze beta-lactam antibiotics,
whereas differences include enzyme origin, amino acid
sequences, spectrum of substrate specificity, catalytic
parameters, and sensitivity to inhibitors. Numerous
attempts have been made to classify these enzymes. The
first methods of classification were based on comparison
of their functional activity, namely on the ability of the
enzyme to cleave different classes of beta-lactam com-
pounds (penicillins, cephalosporins, monobactams, car-
bapenems), sensitivity to inhibitors, and differences in
biochemical parameters [24-26]. As a result, a scheme of
beta-lactamase classification by several functional groups
was designed [27]. A different beta-lactamase classifica-
tion, molecular classification based on a collection of
common structural features, was proposed as well [28].
Four molecular classes are distinguished according to the
level of homology, the presence of conservative regions in
the enzyme structure, and structure of the active center.
Each classification has its merits and shortcomings, but
none is exhaustive; therefore, they are often used togeth-
er. Data on beta-lactamase classification using division
into molecular classes and into functional groups are
given in Table 2.
The first functional group includes enzymes of C
molecular class (AmpC type beta-lactamases) that can be
encoded both by chromosomes and plasmids [30]. A spe-
cific feature of this group is their higher activity towards
cephalosporins compared to penicillins, and these
enzymes also exhibit low sensitivity to inhibitors.
Table 1. Structure of the main groups of beta-lactam
antibiotics (the beta-lactam ring is designated by the dot-
ted line)
Group Structure
Penicillins
Cephalosporins
Monobactams
Carbapenems
MULTIPARAMETRIC DETERMINATION OF BETA-LACTAMASE GENES 1631
BIOCHEMISTRY  (Moscow)   Vol.  75   No.  13   2010
The second functional group, which is most compre-
hensive and diverse, includes beta-lactamases of A and D
classes. Genes of enzymes of this group are incorporated
into plasmids, and therefore efficiency of their transfer
among different strains and, as a result, their spreading
rates are very high. Group 2a includes beta-lactamases of
Gram-positive bacteria Staphylococcus spp. and Bacillus
spp. These enzymes are the most efficient against peni-
cillins (with the exception of oxacillin and its analogs).
The best-known members of group 2b are beta-lacta-
mases TEM-1, TEM-2, and SHV-1. These enzymes also
most efficiently hydrolyze penicillins (except ureidopeni-
cillins). Subgroup 2be includes so-called extended spec-
trum beta-lactamases (ESBL) that are mutants of TEM-
1 and SHV-1 enzymes and are able to cleave efficiently
both penicillins and cephalosporins of generations I-IV.
The same group includes numerous beta-lactamases of
CTX-M type efficiently hydrolyzing cefotaxime. A sepa-
rate group 2br includes TEM and SHV type inhibitor-
resistant mutants. Group 2c includes PSE beta-lacta-
mases of Gram-negative bacteria able to hydrolyze car-
benicillin. Group 2d includes OXA type beta-lactamases
that are members of a separate molecular class D. Some
of these enzymes have the ESBL phenotype. They appear
mainly in P. aeruginosa and A. baumannii strains. It is
assumed that mutation in position 167 is the key one.
Genes of group 2e cefalosporinases are localized on chro-
mosomes. They can be under control of both inducible
(P. vulgaris, C. diversus) and constitutive (Bacteroides
spp., Stenotrophomonas maltophilia) promoters. Group 2f
is formed by carbapenemases, i.e. by beta-lactamases able
to hydrolyze carbapenems.
The third functional group includes zinc-containing
beta-lactamases. Owing to this they are called metallo-
beta-lactamases [31, 32]. According to molecular classi-
fication, they belong to class B. Enzymes of this group
efficiently cleave all types of beta-lactam antibiotics
including carbapenems. They are resistant to inhibitors
of clavulanic acid, sulbactam, and tazobactam, but in
culture they can be inhibited by chelating agents like
EDTA.
All beta-lactamases can be divided by mechanism of
action into serine (containing serine in the enzyme active
center) and metalloenzymes. Serine enzymes include
Main substrate
all groups of beta-lactam
antibiotics except carbapenems
penicillins
penicillins, cephalosporins
penicillins, cephalosporins,
monobactams
penicillins
penicillins, carbenicillin
cephalosporins
penicillins, cephalosporins,
carbapenems
penicillins, oxacillin
most beta-lactams, including
carbapenems
penicillins
Peculiarities of beta-lactamase members
chromosome-encoded AmpC beta-lactamases, some
plasmid-encoded AmpC beta-lactamases — are not
inhibited by clavulanic acid
penicillinases of Gram-positive bacteria — are inhibit-
ed by clavulanic acid
broad spectrum beta-lactamases (TEM-1, TEM-2,
SHV-1) — are inhibited by clavulanic acid
extended spectrum beta-lactamases (ESBL) — are
inhibited by clavulanic acid
inhibitor-resistant beta-lactamases of TEM and SHV
types
carbenicillin-hydrolyzing PSE type beta-lactamases
inducible cephalosporins from Proteus spp. — are
inhibited by clavulanic acid
serine carbapenemases — are inhibited by clavulanic
acid
OXA type beta-lactamases hydrolyzing oxacillin — are
mainly inhibited by clavulanic acid
metallo-beta-lactamases — are not inhibited by clavu-
lanic acid but are inhibited by EDTA
penicillinases not belonging to other groups
Functional
group
1
2
3
4
Subgroup
1
2a
2b
2be
2br
2c
2e
2f
2d
3a, 3b, 3c
not
determined
Molecular
class
C
A
A
A
A
A
A
A
D
B
Table 2. Beta-lactamase classification
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beta-lactamases of molecular classes A, C, and D, where-
as class B beta-lactamases are metalloenzymes.
Most attention has been attracted recently to the
problem of plasmid-encoded ESBL [3, 33]. The term
ESBL was initially used to designate TEM and SHV type
beta-lactamase mutants of 2be functional subgroup able
to hydrolyze oxyiminocephalosporins. Later the meaning
of this term was significantly extended. The following
enzymes were included into the ESBL group: enzymes
with similar profile of substrate specificity but structural-
ly different from CTX-M and VEB type enzymes like
TEM and SHV type mutants with border activity towards
cephalosporins such as TEM-12; beta-lactamases with
different resistance level, not included into functional
subgroup 2be, such as OXA type beta-lactamases and
AmpC beta-lactamase mutants with increased enzymic
activity towards cefepime [34].
Dissemination of Class A Extended
Spectrum Beta-Lactamases
Dissemination of beta-lactamases, including ESBL,
is actively studied in many countries. The number of pub-
lications concerning ESBL abundance in separate clinics,
regions, and countries constantly increases. Data
obtained in Europe [35-37], North [38] and South
America [39], Canada [40], Asian region countries [41,
42], and in the Near East [43] are indicative of increased
resistance to beta-lactam antibiotics among pathogens of
nosocomial and outpatient infections, and of significance
especially ESBL abundance, which is a serious problem
for public health. Comparative analysis of these data indi-
cates that the ESBL fraction among E. coli and Kl. pneu-
moniae pathogens in countries of East and South Europe,
South America, and Asia has already reached 30% and
more; in countries of North Europe, North America, and
Canada it is on average significantly lower and does not
exceed 10-15%. Although TEM and SHV type beta-lac-
tamases were mainly detected in Europe in the 1990s, the
situation changed sharply in the beginning of the XXI
century and at the present time the CTX-M type is preva-
lent in Europe, Asia, and South America [44-49]. The
increase in the CTX-M type beta-lactamase fraction is
exponential, and it is already called pandemic [50]. It is
supposed that such high rate of spreading is due both to
emergence of new mutants and efficient gene transfer
within plasmids and mobile genetic elements. In the USA
the situation is not changed, the SHV and TEM type
beta-lactamases are the most widespread, and the CTX-
M type enzymes were detected only in patients infected
outside the country [35, 51].
Antibiotic resistance, including that to beta-lactam
antibiotics, is also investigated in Russia, and results have
been published in a number of works [52-55]. It is noted
that spreading of beta-lactam resistance among
pathogens of the Enterobacteriaceae family reaches on
average 50-60% for nosocomial infections, and it has
already become a national problem. Increase in the num-
ber of strains simultaneously containing genes of two,
three, and even four beta-lactamase types is found. The
number of such strains already reaches 30%. The ratio of
ESBL types revealed in Russia correlates with data on dif-
ferent ESBL type spreading in Eastern Europe: the CTX-
M beta-lactamases are significantly prevalent (about
80%), and beta-lactamases of SHV type are rather com-
mon. Enzymes of the CTX-M-1 subcluster are the most
often found CTX-M type genes. In recent years signifi-
cant increase in the CTX-M-9 subcluster beta-lactamase
frequency has been recorded [52, 56].
Variety of the Main Types of Class A
Extended Spectrum Beta-Lactamases
On the basis of available data on molecular mecha-
nisms of bacterial resistance to beta-lactam antibiotics
and abundance of different beta-lactamase molecular
classes and functional groups, special attention of
researchers is given to investigation of three main ESBL
types: beta-lactamases of TEM, SHV, and CTX-M types.
All contain serine in the enzyme active center and have
molecular mass about 29 kDa. The main structural fea-
tures of these enzymes will be briefly considered below.
TEM type beta-lactamases. The first characterized
enzyme of this group was TEM-1 penicillinase detected
in E. coli cells isolated from blood of an infected patient
[57]. Later TEM-1-containing plasmids were found in
strains of different members of the Enterobacteriaceae
family, in strains of Pseudomonas aeruginosa, Haemo-
philus influenzae, Neisseria gonorrhoeae, etc. Several years
later the TEM-2 enzyme was isolated, which differs by a
single amino acid mutation Gln39Lys with the same pro-
file of substrate specificity [58]. However, already the next
detected enzyme TEM-3 was characterized by a second
mutation Glu104Lys in addition to the already described
mutation in position 39. This enzyme was able to
hydrolyze cephalosporins, and thus it had a wider spec-
trum of substrates [58]. Now over 170 members of this
type of enzymes have been described and the beta-lacta-
mase database (http://www.lahey.org/studies) is steadily
growing. The primary structure of TEM-1 includes 288
amino acid residues. All described derivatives of TEM
type beta-lactamases are variants of TEM-1 beta-lacta-
mase and differ from original enzyme by single amino
acid substitutions (from one to seven). Mutations are
found in 60 positions, but the frequency of mutations in
each position is very different. Ninety TEM type enzymes
are ESBL. Figure 1 shows the distribution of known
mutations in amino acid sequence of TEM-1 beta-lacta-
mase, which is based on information available in the
GenBank international database. Most frequent are
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mutations in positions 21, 39, 69, 104, 164, 182, 238, 240,
244, 265, and 275. Among them mutations in positions
104, 164, 238, and 240 are keys for extension of substrate
specificity. Introduction of substitutions Glu104Lys,
Arg164Ser(His), and Glu240Lys into TEM-1 results in
change in total charge of the protein globule. Mutation
Gly238Ser results in appearance of enzymes able to
destroy with equal efficiency cefotaxime and ceftazidime,
while enzymes with mutation Arg164Ser are more active
towards ceftazidime and less efficient against cefotaxime
[6]. There are mutations resulting in appearance of
inhibitor-resistant enzymes (IRT, inhibition resistance
phenotype, subgroup 2br) [60]. The following positions of
mutations define resistance to inhibitors: 69, 244, 275,
and 276 [61]. Combination of the first and second type
mutations makes it possible to obtain TEM variants
exhibiting both types of resistance, ESBL + IRT. Six pairs
of beta-lactamases (TEM-1 and TEM-98, TEM-3 and
TEM-14, TEM-10 and TEM-23, TEM-30 and TEM-99,
TEM-34 and TEM-97, TEM-63 and TEM-64) are struc-
turally identical. The use of random and directed mutage-
nesis [62] as well as of insertional mutagenesis [63] made
it possible to obtain artificially synthesized mutants with
extended activity spectrum and to even forecast the emer-
gence of new subtypes of TEM beta-lactamases before
their clinical isolation.
SHV type beta-lactamases. Enzymes of this type
emerged second after TEM type beta lactamases. The
peculiarity of this type of beta-lactamases produced by
Klebsiella pneumoniae is the presence of SHV-1 beta-lacta-
mase encoded by chromosomes [1]. In this case the SHV-
1 enzyme, encoded by the gene localized on plasmids, was
widespread. The SHV-2 mutant differing by a single muta-
tion Gly238Ser was the first described ESBL [64].
The database http://www.lahey.org/studies/ contains
information about 126 mutants of SHV type beta-lacta-
mases. They are derivatives of SHV-1 enzyme and differ
from the latter not only by the presence of point muta-
tions, but by deletions (in SHV-9 and SHV-10) or inserts
(in SHV-16) as well. Figure 2 shows the distribution of
mutations recently detected in amino acid sequence of
SHV-1 beta-lactamase using information from the
GenBank database. Mutations are found in 79 positions;
a deletion in position 54 in SHV-9 and an insert
163DRWET167 in SHV-16 are also described.
Depending on the substitution type, like in the case of
TEM enzymes, mutant SHV differ by the profile of sub-
strate specificity towards cephalosporins. Most frequent
are mutations in positions 35, 238, and 240 and they are
considered as the key ones for changes in the substrate
specificity profile. Beta-lactamase SHV-10 with IRT
resistance phenotype is described. It differs from ESBL
SHV-9 by a single amino acid substitution, Ser130Gly,
but it is not an ESBL itself.
CTX-M type beta-lactamases. Beta-lactamases of
CTX-M type received their name because they more effi-
ciently hydrolyze cefotaxime compared to ceftazidime.
The first enzyme of this type was isolated in 1989 from an
E. coli strain [65]. Later it was called CTX-M-1. Genes of
this enzyme group have plasmid localization. Over 90
enzymes of this type are known. Among the A class
ESBL, the CTX-M group of beta-lactamases is the most
heterogeneous concerning amino acid sequence and,
respectively, the encoding gene structures. The CTX-M
type beta-lactamases are now divided into five subclusters
[66]. Each subcluster consists of the main enzyme (CTX-
M-1, CTX-M-2, CTX-M-8, CTX-M-9, and CTX-M-
25) and its mutants differing by one to several mutations.
Distribution of CTX-M type enzymes by subclusters and
mutations described for each subcluster is shown in Fig.
3. The homology between CTX-M type beta-lactamases
and other types of A class enzymes is marginally pro-
nounced (below 40%) [67]. Much higher homology (over
70%) is observed for the chromosome-encoded enzymes
from Klebsiella oxytoca, Citrobacter diversus, Proteus vul-
garis, and Serratia fonticola [68]. This suggests that the
plasmid-encoded enzymes of CTX-M type originated
from enzymes whose genes are incorporated in chromo-
somes. The difference between CTX-M type beta lacta-
mases on one side and the TEM and SHV type enzymes
on the other side concerning their substrate specificity is
that all of CTX-M type lactamases hydrolyze cephalo-
sporins, i.e. they are ESBL. Differences between CTX-M
type enzymes concern changes in catalytic activity
towards different cephalosporins such as cefotaxime, cef-
tazidime, and cefepime. It was shown that there are also
key mutations for enzymes of this type, such as those in
positions 167 and 240, leading to changes in the substrate
specificity profile. It is noted that the CTX-M type beta-
lactamases are often revealed in infections in outpatients
[19].
Problems of Laboratory Diagnosis of ESBL
The difficulty of detection of ESBL in clinical prac-
tice should be considered as their important feature.
Standard microbiological methods of determination of
infectious pathogen nature and resistance to antibiotics
are based on phenotypic characteristic of microbial
pathogens. They are based on estimation of the antibiotic
minimal inhibitory concentration (MIC) necessary for
inhibition of cell growth in culture as tested by different
methods using panels of antibiotics and their combina-
tions [69, 70]. According to the antibiotic MIC level, the
National Committee for Clinical Laboratory Standards
(NCCLS) (USA) established criteria of sensitivity of
Gram-negative microorganisms to the third generation
cephalosporins only for E. coli and Klebsiella spp.
However, ESBL production is described in practically all
members of the Enterobacteriaceae family and in a num-
ber of other Gram-negative microorganisms. These
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methods require rather much time, and data concerning
antibiotic sensitivity of certain strains can also be inter-
preted ambiguously. Neither traditional microbiological
method based on estimation of microbial phenotype pro-
vides for detection of ESBL in all strains. The “inoculum
effect” or a sharp increase in the antibiotic MIC upon
increase in the pathogen inoculation dose was found, i.e.
the determined level of sensitivity can depend on the cell
concentration in culture. Resistance determination is sig-
nificantly complicated in the presence of several micro-
bial resistance determinants, and the number of such
cases constantly increases. For example, production by E.
coli strains of AmpC beta-lactamases (C class) concealed
the presence of ESBL, and they were not detected when
E-test (5 samples of 7) or a Phoenix automatic analyzer (3
samples of 7) was used [71]. Pseudo-positive results
showing the presence of ESBL in negative samples were
also obtained in the same work, and most such kind of
results (9 false results for 19 samples) was obtained using
diffusion on discs. At best, traditional microbiological
methods of ESBL detection make it possible to estimate
the fact of the presence of an enzyme, but they cannot
give information concerning the presence of a certain
enzyme. Therefore, it becomes obvious that the use of
phenotypic methods for testing sensitivity of bacterial
pathogens is not enough for proper understanding of the
nature and properties of infectious agent [72, 73]. The
necessity of choosing adequate methods of diagnosis for
correct determination of resistance type is actively dis-
cussed [74]. This information can be obtained using
molecular-biological methods of gene analysis.
MOLECULAR-BIOLOGICAL METHODS
FOR IDENTIFICATION OF ANTIBIOTIC
RESISTANCE DETERMINANTS
Analysis of the above-described data shows that study
of the base sequence of beta-lactamase-encoding genes is
necessary for determination of resistance of Gram-nega-
tive microorganisms to beta-lactam antibiotics and for
identification of gene types and existing mutations. Point
mutations in genes (single nucleotide polymorphism
(SNP)) are single nucleotide positions in genomic DNA
Fig. 3. Division of CTX-M type beta-lactamases into subclusters and positions of amino acid substitutions in them described before January
2010.
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for which in a certain population there are different vari-
ants of sequences (alleles) [75]. The detection of SNPs
requires either identification of complete base sequence of
the gene or structure of its fragments. All presently avail-
able molecular-biological methods of base sequence
analysis are based on amplification of genes from biologi-
cal material. Polymerase chain reaction (PCR) is most
often used for this. It is necessary to use additional meth-
ods for determination of complete or partial structure of
DNA synthesized during the reaction. The “gold stan-
dard” of gene molecular typing is sequencing or determi-
nation of primary structure, i.e. determination of base
sequence in the gene strand. Sequencing can be used to
identify both known and new gene variants. The main dis-
advantage of this method is its labor consumption and rel-
atively high cost. The use of sequencing is difficult when it
is necessary to detect several genes in the same sample,
especially when these genes belong to the same genetic
group where distinctions include separate mutations.
Multiplex PCR
For simultaneous amplification of several genes mul-
tiplex (multiprimer) PCR or the reaction of co-amplifi-
cation of several DNA templates in the same reaction
medium using several pairs of primers are used. Design of
primers and detection of probability of unspecific frag-
ment amplification are very important for increase in
specificity of the method. There are now multiplex PCR
techniques for simultaneous amplification of gene frag-
ments of three main ESBL types (TEM, SHV, CTX-M)
[76]. The method can assign the enzyme gene to a certain
beta-lactamase type. More detailed gene differentiation
by multiplex PCR is possible at the subcluster level for
CTX-M type ESBL, but in this case analysis is carried out
only for the same type enzymes (in this case CTX-M) [77,
78]. The multiplex PCR technique becomes increasingly
important in combination with different methods provid-
ing more detailed structural characteristics of the gene.
Thus, the method of multiplex PCR was elaborated for
simultaneous amplification of CTX-M type beta-lacta-
mases, but owing to amplification of genes of different
subclusters in the form of equal size fragments, further
investigation of their structure is necessary for the assign-
ment of gene type [79].
Real-Time Polymerase Chain Reaction
Real-time PCR (RT-PCR) is an actively developing
technology. Different types of fluorescent dyes are used as
labels. To determine the result of the labeled oligonu-
cleotide hybridization, either donor fluorophore energy
transfer to an acceptor with a different emission spectrum
or energy transfer to a fluorescence quencher is used.
TaqMan technology is based on a method of destruc-
tible probes. Oligonucleotide is modified by a fluorophore
and fluorescence quencher. In the absence of a target the
fluorophore and quencher are drawn together and fluo-
rescence is inhibited. In the presence of a specific tem-
plate the probe is hybridized to an amplicon, which
results in its destruction and emergence of fluorescence
due to 5′ exonuclease activity of Taq polymerase (the abil-
ity to hydrolyze DNA sequence in the 5′→3′ direction).
The use of this approach was described for identification
of a subcluster of CTX-M type ESBL genes [80]. The
method is characterized by high rate and good productiv-
ity compared to standard PCR techniques.
A different variant of RT-PCR is the method of adja-
cent probes based on use of two oligonucleotide probes
hybridized to template DNA in the immediate vicinity of
each other. One probe includes a donor fluorophore and
the other contains an acceptor fluorophore. Probe
hybridization with the template brings the fluorophores
together and energy transfer from donor to acceptor (flu-
orescence resonance energy transfer) occurs. This
approach became widely adapted to SNP detection.
Thus, its abilities were demonstrated in detection of key
mutations in the SHV, TEM, and CTX-M type ESBLs
[81-84]. The method is limited by the possibility of simul-
taneous detection of only a few SNPs due to the limited
set of fluorescent labels.
Methods for Analysis of Amplification Products
Used for Gene Identification
Restriction fragment length polymorphism (RFLP)
method. This method is used for detection of polymor-
phous DNA regions. To do this, the amplified gene is
cleaved by an appropriate restriction endonuclease and
changes in restriction sites are determined [85]. For each
gene type its own set of restriction products is obtained
and analyzed by electrophoresis. The method indicates
the presence of variations in base sequence but requires
further analysis of fragments or comparison with a sepa-
ration profile of known gene variants. This approach was
applied to identification of SHV type beta-lactamases in
Pseudomonas aeruginosa strains by the presence of key
mutations in positions 35, 238, and 240 [86]. The method
is simple enough in practice and can be used for screen-
ing a large number of samples; its limitation is the possi-
bility of detection of only mutations localized in restric-
tion sites as well as complications in revealing numerous
mutations.
Method of analysis of conformational distinctions
between single-stranded DNA fragments. This method
(SSCP, single strand conformation polymorphism) was
elaborated for SNP analysis and is based on variations of
single-stranded DNA conformation after denaturation.
This is demonstrated by changes in electrophoretic
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mobility. The SSCP shows the presence of changes in
nucleotide sequence, but it requires further analysis of
fragments or comparison with the separation profile of
known gene variants. The method was used for analysis of
TEM and SHV type ESBL [87, 88].
Method of time-of-flight mass spectrometry. An
alternative to existing methods for detection of polymor-
phous DNA regions is differential sequencing by time-of-
flight mass spectrometry. The ionized DNA molecules are
separated from the substrate using MALDI (matrix-
assisted laser desorption/ionization) technique, acceler-
ated in an electric field, and sent to a detector via a vacu-
um chamber. The registered time of motion is inversely
proportional to the speed of the molecule, which in turn
is in direct proportion to the mass-to-charge ratio of the
molecule. The mass-to-charge ratio is unique for each
molecule and is defined exclusively by its base sequence;
therefore, the sensitivity of the method is very high. The
time spent for analysis of each sample by this method is
only a few seconds. The possibility of use of this approach
for rapid detection of TEM type ESBL by key mutations
in positions 104, 164, and 238 was shown [89]. The sensi-
tivity of the method is high, and 50 bacterial cells in a
sample are enough for determination. Determination of
nucleotide type in mutation position and, respectively,
recognition of genes with various substitutions is possible.
The method is characterized by high productivity and the
possibility of simultaneous analysis of several samples.
Among clear advantages of the method is the possibility to
detect new mutations that have not been previously
described.
High performance liquid chromatography method.
The method of high performance liquid chromatography
(HPLC) under denaturing conditions was elaborated for
analysis of the product formed during amplification, and
it was used for detection of CTX-M type ESBL [90].
Genes of CTX-M type beta-lactamases were amplified
using multiplex PCR [78], and in this case the fragments
of genes belonging to different subclusters differed in size.
Then amplified fragments were mixed with an equal
amount of DNA of control strains producing CTX-M
type beta-lactamases that were characterized by gene typ-
ing. Mixtures were quickly heated for denaturation and
then cooled at a certain rate for formation of homo- and
hetero-DNA duplexes. The duplexes were analyzed by
HPLC in an acetonitrile gradient. The temperature was
optimized to make possible distinguishing 13 CTX-M
beta-lactamase gene variants by the shape of chromato-
graphic peaks. To achieve maximal sensitivity and speci-
ficity, it was necessary to analyze duplexes for CTX-M-1
subcluster at two temperatures, 64 and 65°C, for subclus-
ters CTX-M-2 and 25/26 at 64°C, and for CTX-M-9 at
67°C. The method is characterized by high productivity
(100 samples in 6 h), and its cost is significantly lower
than that for sequencing. The authors of this work also
suppose that it will be possible to follow the emergence of
new mutations by appearance of anomalous chromato-
graphic peaks. A limitation of the method is that it deter-
mines only some mutations.
Pyrosequencing method. Pyrosequencing has been
proposed for analysis of mutations. The method is based
on detection of pyrophosphate cleavage during DNA syn-
thesis. Pyrophosphate is the first substrate in a cascade of
enzymatic reactions resulting in emission of light. The
intensity of the emitted light is in proportion with the
number of incorporated nucleotides. Detection of emit-
ted light intensity in real time makes possible rapid iden-
tification of short gene fragments up to 100 bp.
Pyrosequencing was used for SNP detection in genes of
CTX-M type ESBL [91] and of GES type ESBL [92].
Determination of genetic subcluster for CTX-M type
beta-lactamases was possible during analysis of 13 bp long
DNA fragment. Analysis of another 16 bp gene region
identified separate subtypes of CTX-M beta-lactamases.
The method is characterized by the very high rate of
analysis; total determination time, including PCR, is 3 h.
Hybridization. Hybridization on insoluble supports
proposed by E. Southern [93] is used for specific detec-
tion of individual DNA fragments. This method is often
used after DNA fragmentation like that using RFLP, after
which electrophoretically separated fragments are trans-
ferred onto porous membrane by immunoblotting.
Hybridization (complementary interaction of polynu-
cleotide strand under study with labeled oligonucleotide)
is used for identification. In this case the labeled oligonu-
cleotide is the “probe”. The label activity is determined in
DNA duplexes on the support after washing.
Hybridization analysis was used for detection of ESBL
and AmpC beta-lactamases upon screening Salmonella
enterica and Pseudomonas aeruginosa strains [94, 95]. The
use of hybridization in amplified DNA detection signifi-
cantly increases the specificity of gene fragment determi-
nation. Depending on the type of the label introduced
into the oligonucleotide probe (fluorescent dyes, hap-
tens), different ways of detection of hybridization com-
plex are used (direct measurement of fluorescence, detec-
tion using specific antibody conjugates with enzyme).
Approaches developed for gene detection by hybridiza-
tion on solid phase served as a prototype for design of
hybridization analysis on microarrays.
Method of hybridization analysis on microarrays. The
first report concerning the technology of biological
microarrays for investigation of gene expression level
appeared in 1995 [96]. During the past 10 years this tech-
nology has significantly developed and gains more areas for
its application. A DNA-microarray presents a set of spots
distributed in a strictly determined order on a glass or poly-
mer surface of a small size (1-10 cm2); each spot contains
single-stranded oligonucleotides with a particular base
sequence. The number of such spots and thus the number
of different base sequences can reach 1·106/cm2, their
length varying from 15 to 1000 nucleotides. The method of
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hybridization analysis on microarrays is based on amplifi-
cation of analyzed DNA region with simultaneous intro-
duction of label and following hybridization of the ana-
lyzed base sequence on the microchip surface with
oligonucleotides or DNA sequences immobilized in a def-
inite order [97]. The difference between hybridization
analysis on microarrays and classical hybridization is that
oligonucleotides called probes are immobilized on the sup-
port and the label is introduced into the analyzed DNA.
The result of hybridization of the labeled DNA sample
with immobilized oligonucleotides (probes) is determined
by the label activity on the support using special devices –
high resolution scanners. Mainly passive hybridization is
used in DNA microarrays, i.e. the interaction of the DNA
target with the immobilized oligonucleotides is a random
process and depends on several factors such as the length of
DNA probe, chemical composition of labeled DNA target,
hybridization temperature, composition of hybridization
mixture, and the type of introduced label.
Different types of labels for hybridization analysis on
microarrays are used. Radioactive label, usually P33 incor-
porated into the phosphate residue of the nucleotide
introduced into the DNA strand during its synthesis, was
proposed for labeling of the analyzed DNA [93]. In this
case each DNA molecule contains several atoms of
radioactive phosphorus, the maximal number of which
can be equal to the number of nucleotides. The presence
of several labels within the analyzed DNA increases sen-
sitivity of the hybridization assay. The use of isotope tech-
nology in microarrays makes it possible to achieve high
sensitivity, although there are some limitations. First of
all, they are connected with insufficiently high resolution
of the film used as the detector as well as with difficulty of
work with radioactive materials.
The fluorescent label is now the most widespread in
hybridization analysis on DNA microarrays. In this case,
dyes directly joined to the sequence of interest can be
used as generators of the fluorescent signal [98]. The flu-
orescent label is usually introduced into DNA during
PCR as a component of primers or fluorescent dye conju-
gates with dCTP or dUTP [99]. Methods of hybridization
analysis using nanoparticles of gold with following visual
[100] or electrochemical detection [101] have been
described.
So-called “indirect” labeling with biotin was pro-
posed, and biotin is revealed by a conjugate of strepta-
vidin with fluorescent dye [102] or with horseradish per-
oxidase [103] or alkaline phosphatase enzymes [104].
Hybridization analysis on microarrays has significant
advantages over traditional molecular-biological meth-
ods, which include the possibility of multiparametric
determination, i.e. determination of numerous parame-
ters (from tens to hundreds and even thousands of genes
and mutations in them) in a single sample due to carrying
out numerous parallel reactions on the microchip surface
under identical conditions.
The microchip technology is a principally new level
of laboratory investigations making possible hundreds and
thousands of parallel reactions. Examples of the applica-
tion of this method for identification and typing of differ-
ent genes responsible for emergence of antibiotic resist-
ance among microorganisms will be considered in sepa-
rate sections.
METHODS OF HYBRIDIZATION ANALYSIS
ON MICROARRAYS FOR IDENTIFICATION
OF SEVERAL ANTIBIOTIC RESISTANCE
DETERMINANTS
Microarrays for Gene Identification
Potentials of hybridization analysis on microarrays
providing for multiparametric gene determination were
demonstrated upon revealing genes responsible for devel-
opment of antibiotic resistance, including that to beta-
lactam antibiotics.
A method was proposed for determination of nine
beta-lactamase types (TEM, SHV, PSE, OXA, FOX,
MEN, SMY, OXY, and AmpC) on a glass microchip with
fluorescent detection [105]. Specific probes of about
1000 bp were amplified by PCR using specific primers.
The studied DNA was amplified by multiplex PCR with
introduction of fluorescent label. Hybridization was car-
ried out at 70°C for 2 h. The possibility of determination
of resistance genes using just a single bacterium as a PCR
template was shown. Thus, it is supposed that the sensi-
tivity of the method makes the analysis possible without
preliminary culturing of clinical samples. The possibility
of detection of two type resistance genes (OXY and PSE)
in the same sample was shown experimentally.
A method was developed for determination of 23
resistance genes and 25 virulence genes in Salmonella spp.
and E. coli strains [106]. Sequences up to 400-800 bp
long, obtained by PCR, were immobilized on a chip of
membrane support. Digoxygenin, revealed by the anti-
digoxygenin antibody conjugate with alkaline phos-
phatase, was used as the DNA label. The enzyme on the
support was detected colorimetrically. Beta-lactamases of
TEM, CMY, and PSE types were revealed among differ-
ent antibiotic resistance determinants.
A method was proposed for typing St. aureus spp., E.
coli spp., and Ps. aeruginosa spp. strains with simultane-
ous identification of resistance determinants of these bac-
teria to several groups of antibiotics [107]. About 120 spe-
cific probes of 200-800 bp were amplified from recombi-
nant plasmids and applied onto a glass microchip. Probes
for pathogen type identification were tested along with
probes homologous to regions of genes encoding viru-
lence factors and antibiotic resistance determinants in St.
aureus strains to oxacillin-methicillin (mecA), gen-
tamycin (aacA-aphD), erythromycin (ermA), and peni-
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cillin (blaZ), and in E. coli strains to penicillin (blaTEM-106)
and aminoglycosides (aacC2). Blood samples were culti-
vated on special media without further DNA amplifica-
tion. Total DNA labeled by several types of fluorescent
dyes was used for analysis. Hybridization time was 18 h at
60°C. Although DNA isolated from blood of infected
patient contains bacterial and human DNA mixture, high
specificity of identification was achieved. There was 100%
coincidence between results of identification on the
microchip and phenotyping data for St. aureus spp. resist-
ant to penicillin, oxacillin, erythromycin, and gen-
tamycin. Among advantages of the method the following
can be mentioned: i) recombinant plasmids were used for
synthesis of the probe panel, which makes easy extension
of probe amount and composition; ii) the use of total
DNA for analysis; iii) the absence of an amplification
stage of the analyzed DNA; iv) preliminary pathogen typ-
ing is not necessary. From the point of view of ESBL
identification, the use of sufficiently long probes is a dis-
advantage because it makes it impossible to use this
approach for detection of point mutations in genes.
Hybridization analysis on microarrays with colori-
metric detection was elaborated for identification of 90
antibiotic resistance genes in Gram-positive microorgan-
isms [108]. For identification of 81 genes, two probes spe-
cific for each homologous region of the studied genes
were chosen, while for nine genes one probe was chosen
for each. Altogether, 137 oligonucleotides of 26-33 bp in
length were immobilized on a microchip, and specificity
of gene detection was studied for 125 probes. Biotin was
used as the label. It was introduced into the DNA during
PCR and then was detected on the microchip surface by
incubation with streptavidin–peroxidase conjugate and
following detection of enzyme activity. The required
specificity of analysis was achieved upon hybridization for
1 h at 60°C.
In this work advantages of hybridization on microar-
rays, which exhibits higher specificity than PCR, are dis-
cussed. The use of oligonucleotide probes also has advan-
tages over longer PCR products due both to higher speci-
ficity and reduced time of analysis. The possibility of
automating different stages of the method undoubtedly is
among its positive characteristics: a microchip is placed
into a special Array Tube (technology of the Clondiag
company), which makes significantly simpler the per-
formance of stages of hybridization, washing, and detec-
tion. The impossibility of specific detection of point
mutations due to rather long oligonucleotide probes can
be considered as a drawback of the method.
The same technology was used in a microarray elab-
orated for 47 genes responsible for development of resist-
ance to five groups of antibiotics (beta-lactams, amino-
glycosides, trimethoprim, sulfonamides, tetracycline,
chloramphenicol, and quinolones) in Gram-negative
bacteria [109]. The microarray was tested using 50 clinical
strains of E. coli and 37 clinical strains of Salmonella spp.
In 99% of the cases the results of resistance determinant
detection by the microarray technique coincided with
those of PCR carried out in the form of several multiplex
reactions. In E. coli strains many more resistance genes
were found (13 resistance determinants were revealed in
over 30% of the samples) compared to Salmonella spp.
(seven resistance determinants were found). As to beta-
lactamase identification, the method only allowed deter-
mination of beta-lactamase TEM and SHV gene type.
Genes of CTX-M and OXA type ESBL were revealed only
at the subcluster level (CTX-M-1, CTX-M-2, CTX-M-9;
OXA-1, OXA-2, OXA-7, and OXA-9).
A microarray was designed for simultaneous deter-
mination of 65 genes responsible for development of
resistance to macrolides in several types of Gram-nega-
tive and Gram-positive bacteria [110]. A panel of 100
probes of 40-60 bases in length was used for gene typing.
The probes were applied onto a glass microchip.
Genomic DNA was isolated from bacterial cultures, fluo-
rescent label was introduced into it, and it was hybridized
on the microchip. Good specificity of the method was
demonstrated, and it was possible to reveal for the first
time the presence of one of the msr(SA) genes responsi-
ble for the efflux system in the Gram-negative microor-
ganism B. fragilis.
Microarrays for SNP Determination
Hybridization analysis on microarrays allows both
identification of genes and recognition of single structur-
al distinctions in the probe and in the hybridized
sequence, which is necessary for SNP determination. For
this aim the method of allele-specific hybridization is
most often used.
Allele-specific hybridization on a glass microarray
was used to determine fluoroquinolone-resistant E. coli
strains [111]. Oligonucleotide structures were proposed
for nucleotide polymorphism identification in the gyrA
gene, encoding amino acid substitutions in positions 83
and 87. Oligonucleotides were composed of 19 bases, and
the detected mutation was in the central position. A group
of four oligonucleotides differing in the base at central
position was used for detection of one mutation.
Optimization of oligonucleotide structures provided high
specificity of determination: in all studied cases the result
of complementary hybridization exceeded that for non-
complementary hybridization by 4-13-fold. In the work
an attempt was made to design universal probes using ino-
sine, but this resulted in significant lowering of the ana-
lytical signals.
The method of hybridization analysis on microarray
was described for detection of several types of ESBLs
(TEM, SHV, CTX-M-3, CTX-M-9, MOX, CMY, DHA,
ACC, FOX, MIR-1, and ACT-1) and plasmid-encoded
AmpC beta-lactamase, including detection of six point
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mutations in the SHV beta-lactamase gene [112].
Oligonucleotide probes of 19-23 bases in length were
immobilized on a glass microarray. Two oligonucleotides
with base sequence complementary to the wild type and
mutant enzymes were used for detection of point muta-
tions. An asymmetric two-step PCR technique was used
for amplification. In the first step a mixture of specific
primers was used for amplification of the studied gene
fragments. The second step was carried out at a higher
temperature of annealing with universal fluorescence-
labeled primers in higher concentrations. Optimization of
conditions provided mainly single-stranded molecules,
which made it possible to exclude the stage of DNA
denaturation before hybridization. Rather good correla-
tion was established between data of typing on the
microarray and data of phenotyping and sequencing.
For identification of nine resistance determinants
and one mutation in the grlA gene encoding the α subunit
of DNA topoisomerase in clinical sample of St. aureus, a
microarray was designed on the basis of glass-immobi-
lized oligonucleotides [113]. The oligonucleotides were
17-24 bases long. A set of four oligonucleotides was used
for detection of point mutation. A fluorescent label was
introduced into the DNA after amplification. Hybridiza-
tion on the microarray was carried out for 4 h at 42°C.
The microarray enables simultaneous testing of bacterial
resistance to beta-lactams, tetracyclines, gentamycin,
macrolides, streptogramin A compounds, and fluoro-
quinolones. The detection limit was 100 pg DNA, which
corresponds to 104 bacterial cells.
An original technology of gel biological chips for
gene and SNP identification was designed at the
Engelhardt Institute of Molecular Biology [114]. In this
method oligonucleotide probes are immobilized on the
microarray surface in the form of a hemispherical hydro-
gel of cells from 100 µm to 1 mm in diameter.
Immobilization is carried out with formation of covalent
bonds upon ultraviolet irradiation. The high-porosity gel
makes possible immobilization of oligonucleotides of up
to 200 bases. A fluorescent dye is introduced into the ana-
lyzed DNA. Electric fields transverse to the microarray
surface introduces hydrodynamic flows that accelerate
the kinetics of the labeled DNA hybridization with
oligonucleotides. The probe concentration in the gel
microarrays exceeds almost 103-fold that in the case of
planar microarrays, which significantly increases the sen-
sitivity of the method. This approach was used for detec-
tion of antibiotic-resistant forms of Mycobacterium tuber-
culosis [115]. For this aim SNPs that define resistance to
rifampicin were determined in 28 positions of the rpoB
gene as well as SNPs responsible for resistance to isoni-
azid were determined in 11 positions of the katG gene, in
five positions of the promoter of the inhA gene, and in five
positions of the regulatory region of gene ahpC-oxyR.
Fluorescent label was introduced into PCR primers, and
the analysis time was 12 h.
METHODS OF MULTIPARAMETRIC
HYBRIDIZATION ANALYSIS
FOR IDENTIFICATION
OF EXTENDED SPECTRUM BETA-LACTAMASES
The variety of beta-lactamase types and variants
makes rather complicated the problem of their identifica-
tion for clinical laboratory diagnosis and epidemiological
monitoring of the emergence and spreading of infection.
The existence of several molecular classes of enzymes as
well as their variability makes it necessary to use methods
able to provide for simultaneous detection both of several
gene types and mutations in them. At first sight it may
seem that the problem of ESBL identification is more
highly specialized, because formally ESBL are a small
part of the beta-lactamase family and belong to one func-
tional subgroup of 12 already described. However this
subgroup is one of most numerous concerning the detect-
ed and described gene variants and point mutations in
them. Therefore ESBL gene typing, i.e. determination of
genotype of an enzyme produced by the bacterial strain
under study, suggests simultaneous determination of sev-
eral gene types and several hundreds of mutations in
them. Data on the use of various molecular-genetic
methods for detection of the main ESBL types that are
based on PCR modifications and analysis of amplifica-
tion products by different methods are given in Table 3.
The use of methods based on PCR and the combination
of PCR with methods of product analysis based on gel
electrophoresis, chromatography, and mini-sequencing
usually allows determination of only a limited number of
genes and SNPs in a single analysis. Therefore, these
methods cannot be used when identification of enzyme
genotype is required. Among the total variety of described
molecular methods, methods of multiparametric
hybridization analysis on microarrays, considered in this
section, seem to be the only adequate technologies for
ESBL multiparametric gene typing.
The method of hybridization analysis with biotin
label revealed by the streptavidin–peroxidase conjugate
with subsequent chemiluminescent enzyme detection was
proposed for identification of the most widespread vari-
ants of CTX-M type beta-lactamase genes [119]. Biotin
was introduced into reverse primers used for multiplex
PCR. Primer structure was selected so that amplified
fragments of the CTX-M beta-lactamase gene belonging
to four different genetic subclusters differed in size.
Enzymes of CTX-M-8 and CTX-M-25 types were com-
bined in a single subcluster. On the membrane macroar-
ray oligonucleotides were immobilized as bands in an
immunoblotter. For hybridization, the array was turned
through 90° relative to the initial orientation, and the
immunoblotter channels were filled with the amplified
DNA solutions in hybridization buffer. The peculiarity of
this method is hybridization performed in kinetic regime;
to increase specificity of analysis, the sample was washed
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Reference
76
125
83, 84
88
86
89
120
81, 82, 84
86
87
116, 117
77-79 
80, 84
118
90
91
119
123
Method
Multiplex PCR
Hybridization on microarray
RT-PCR
PCR–SSCP
PCR–RFLP
PCR–time-of-flight mass
spectrometry
PCR–hybridization 
on microarray
RT-PCR
PCR–RFLP
PCR–SSCP
Multiple PCR
Multiplex PCR
RT-PCR
PCR–RFLP
PCR–HPLC
RT-PCR–pyrosequencing
PCR–hybridization 
on macroarray
PCR–hybridization 
on microarray
Identification level
gene type identification
gene type and known SNP identifica-
tion on one chip
identification of type and key SNPs
detection of individual SNPs
detection of individual SNPs
detection of key SNPs
identification of gene type and 96% 
of described SNPs on one microarray
identification of type and key SNPs
detection of G238S mutation
detection of individual SNPs
subcluster identification
subcluster identification
type identification
subcluster identification 
and detection of key SNPs
subcluster identification
identification of subcluster 
and individual SNPs
identification of subcluster 
and individual SNPs
identification of separate SNPs 
for each CTX-M subtype
identification of gene type and all
described SNPs on one microarray
Limitations of method
impossibility of mutation detection
detection of only known SNPs
determination of a limited number of SNPs
detection of only known SNPs
determination of a limited number of SNPs
impossibility of mutation detection
determination of a limited number of SNPs
individual chips for identification 
of different subclusters, detection 
of limited number of SNPs
detection of only known SNPs
Table 3. Molecular-genetic methods of ESBL identification
Main ESBL types (TEM, SHV, CTX-M) in one analysis
TEM type ESBL
SHV type ESBL
CTX-M type ESBL
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at enhanced temperature. After washing, the amount of
label in DNA duplexes was determined on the support by
peroxidase activity in the chemiluminescence reaction.
Differences in Tm of selected oligonucleotide panels
did not allow selection of the same conditions for
hybridization analysis for all four genetic subclusters.
Because of this, a separate membrane array and different
temperatures of washing buffer were used after hybridiza-
tion (from 58 to 65°C) for detection of mutations within
each subcluster. To determine which array is necessary for
typing of any sample, the subcluster type was determined
by the size of amplicon obtained in multiplex PCR. The
selected oligonucleotides enabled identification of the
presently most widespread gene variants of the CTX-M
type beta-lactamases: CTX-M-1, -2, -3, -9, -14, and -15.
High productivity of this method (43 samples can be tested
in parallel), rather short time of analysis (about 7 h), and
inexpensive equipment can be considered as its advantages.
Limitations of this method are both unusual conditions of
hybridization analysis for different subclusters of CTX-M
beta-lactamase genes and a limited number of determined
SNPs (four of each SNP for subclusters CTX-M-1, CTX-
M-2, and CTX-M-8 and five for subcluster CTX-M-9).
The method of hybridization analysis on glass
microarrays was proposed for TEM type beta-lactamase
gene typing on the basis of determination of all SNPs
[120]. The fluorescent label used in this method was
introduced into the gene during PCR in the form of mod-
ified deoxyribocytosine triphosphates (dCTP-Cy5). The
scheme of the method of hybridization analysis with flu-
orescent detection is shown in Fig. 4a. Amplified labeled
DNA was fragmented before hybridization by DNase for
obtaining approximately 50-base-long oligonucleotide
strands. It was shown earlier that this increases hybridiza-
tion efficiency [121]. Hybridization was followed by scan-
ning of fluorescence activity on the microarray surface.
For one SNP determination a set of four oligonucleotides
with unique base sequence corresponding to the TEM
beta-lactamase gene structure in a given region and dif-
fering from each other by just a single nucleotide in the
central position, which could be one of four nucleotides
A, G, C, or T, was used (Fig. 5a). The most stable duplex
is formed in the case of the labeled fragment hybridiza-
tion with a fully complementary oligonucleotide, and
correspondingly, in this case a higher analytical signal
(PM, perfect match) is detected (Fig. 5b). If duplexes are
formed during hybridization with three other oligonu-
cleotides or with only some of them, then the observed
signal (MM, mismatch) is indicative of the level of unspe-
cific hybridization.
Molecular design of oligonucleotide structures for 41
SNPs in TEM beta-lactamase genes was carried out in
this work. The following rules of oligonucleotide structure
selection for SNP recognition were observed [122]: (i)
oligonucleotides should be 17-26 bases long; (ii) the G +
C content should be in the range of 35-70%; (iii) the
probability of dimer and cyclic structure formation
should be minimal; (iv) Tm differences for different
oligonucleotide groups should not exceed 5-10°C.
The principle of internal signal normalization was
used for nucleotide type determination in the analyzed
gene position. For this aim all results of hybridization
within the set of four oligonucleotides were normalized to
the signal of complementary hybridization. In this way
hybridization signals were obtained in relative units: sig-
nal of complementary hybridization became equal to 1,
whereas the other three signals of non-complementary
hybridization were expressed in its parts (Fig. 5c):
RIPM = IPM/IPM = 1,
RIMM = IMM/IPM,
Fig. 4. Scheme of DNA hybridization analysis on microarrays
with different labels: a) fluorescent dye; b) biotin (Bt). Strp, strep-
tavidin; HRP, horseradish peroxidase.
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Fig. 5. a) Scheme of point mutation detection in gene by allele-
specific hybridization. b) The result of point mutation detection
in a gene by hybridization analysis on microchip. c) Representa-
tion of results of hybridization analysis for detection of a single
mutation in a gene in relative units.
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a
b
c
Fig. 6. Intensity profiles of hybridization signals of labeled DNA amplified from control strain producing CTX-M-3 beta-lactamase. Mutation
numbers in CTX-M-1 beta-lactamase sequence are marked on the abscissa. a) Cy3 label, hybridization conditions 45°C, 1 h; b) Cy3 label,
hybridization conditions 47°C, 1 h; c) biotin label, hybridization conditions 45°C, 2 h.
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where IPM is intensity of signal of hybridization with fully
complementary oligonucleotide, IMM is intensity of signal
of hybridization with the other three oligonucleotides,
RIPM is fraction of complementary hybridization, RIMM is
fraction of noncomplementary (unspecific) hybridiza-
tion.
Parameter of unspecific hybridization fraction
RIMM = IMM/IPM was used for estimation of SNP detec-
tion specificity. If the fraction of unspecific hybridization
exceeded 0.7, then the SNP detection was considered as
unspecific. Molecular design of oligonucleotide struc-
tures for SNP detection in TEM type beta-lactamases
allowed highly specific detection of mutations: over 99%
of RIMM values did not exceed 0.4, and only a single group
of oligonucleotides was characterized by RIMM = 0.52.
The authors of this work tried to reduce significantly the
hybridization time from three hours to 15 min in order to
elaborate a method for express analysis of resistant strains
that could be used in clinical laboratories. It was found
that in the case of 1-h-long hybridization reaction, in
84% of cases RIMM values are not higher than 0.4, 14% of
RIMM values are not higher than 0.6, while in the case of a
single mutation an RIMM value close to 0.7 is observed.
Reduction of hybridization time to 30 min revealed simi-
lar specificity with lower reproducibility. Further reduc-
tion of hybridization time to 15 min resulted in significant
lowering of the detection specificity: six positions were
identified incorrectly, while 21% of RIMM values exceeded
0.7. Thus, it was found that hybridization time could be
reduced to 30 min. In this case total time of analysis was
3.5 h, which is a significant improvement compared to
standard phenotypic tests taking 2-3 days.
We have used the same approach for elaboration of
hybridization analysis on microarrays for gene typing of
CTX-M type beta lactamases [123] that differ from other
class A ESBL by lower homology between the same type
genes. Because of this, oligonucleotide structures for
genetic subcluster identification were also selected along
with oligonucleotides for identification of point muta-
tions in genes.
On the whole, the CTX-M type beta lactamases dif-
fer from TEM and SHV type beta-lactamases by higher
G–C content, which resulted in a higher level of unspe-
cific hybridization compared to previous data [120].
Thorough molecular design of specific oligonucleotide
structures was carried out for lowering the level of unspe-
cific hybridization. Introduction of artificial substitutions
into oligonucleotide structure was used to increase speci-
ficity of the central oligonucleotide detection. Results of
testing of the CTX-M-3 beta-lactamase-producing con-
trol strain by hybridization analysis on microarrays using
fluorescent dye Cy3 as DNA label are shown in Fig. 6a.
Specificity of separate SNP detection during hybridiza-
tion at 45°C was not high enough: 16% of RIMM values did
not exceed 0.7. On increase of hybridization temperature
to 47°C the specificity of SNP identification was
improved insignificantly: the fraction of RIMM values
below 0.4 increased, but 10% of RIMM values exceeded 0.7
(Fig. 6b).
Since hybridization efficiency and specificity are
defined by the oligonucleotide strand secondary structure
that can be influenced by the introduced label, we studied
the effect of an alternative biotin label having significant-
ly smaller size compared to fluorescent labels of the
cyanin group [124]. The scheme of hybridization analysis
with biotin label is shown in Fig. 4b. Biotin was intro-
duced into the beta-lactamase gene during PCR (in the
form of dUTP-biotin). The introduced biotin was
revealed using the streptavidin–horseradish peroxidase
(HRP) conjugate and HRP colorimetric detection with
substrates whose oxidation is accompanied by formation
of intensely stained product adsorbed on the glass surface
near the enzyme molecules. Figure 6c shows results of
testing of the CTX-M-3 beta-lactamase-producing con-
trol strain by hybridization analysis on microarrays using
biotin label. The specificity of SNP revealed by hybridiza-
tion analysis with biotin label was significantly higher
even at 45°C. Data in Fig. 7 compare specificity in reveal-
ing 19 different SNPs described for the CTX-M-1 sub-
cluster beta-lactamases upon hybridization analysis with
fluorescent and colorimetric detection. The use of biotin
label provided the best specificity in detection of point
mutations: 94% of RIMM values were below 0.4. All in all,
oligonucleotide probe structures were selected for detec-
tion of 67 SNPs in CTX-M type beta-lactamase genes.
The elaborated method was proven using a collection of
94 clinical microbial strains of the Enterobacteriaceae
family. A full 100% coincidence was obtained between
gene typing by hybridization analysis on the microarray
and complete gene sequencing.
Thus experiments on multiparametric SNP typing in
TEM and CTX-M type beta-lactamase genes by allele-
specific hybridization on microarrays revealed the good
potential of this method. The peculiarity of the consid-
ered approach is its sufficient universality and the possi-
bility of extension of the type of identified genes and
mutations.
Later this was confirmed during elaboration of inte-
grated technique for simultaneous gene typing for the
three most clinically important ESBL (TEM, SHV, and
CTX-M types) on the basis of SNP detection in encoding
genes [125]. Two multiplex PCRs were elaborated for
gene amplification: in one of them genes of TEM and
SHV type beta-lactamases were amplified, while the
other was used for amplification of the CTX-M type beta-
lactamase two gene fragments belonging to all four sub-
clusters and comprising in aggregate the full-size gene
(open reading frame). The fluorescent label Cy3 intro-
duced into the gene during PCR was used as the DNA
label. A set of four oligonucleotides differing in
nucleotide type in the central position or in that close to
central was used for one SNP detection. It was proposed
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to place oligonucleotide groups on the microchip in the
form of modules, each of which contains oligonucleotide
groups for detection of mutations in the same type beta-
lactamase genes. This will make possible in future to add
new oligonucleotide groups for revealing new mutations
in analyzed gene types as well as new oligonucleotide
modules for revealing new beta-lactamase types.
The main problem of integration of the earlier devel-
oped oligonucleotide panels for gene typing of TEM,
SHV, and CTX-M type beta-lactamases into a single
microarray is how to optimize the conditions providing
the efficient hybridization of structurally different
oligonucleotides with retention of high sensitivity and
specificity of analysis. Due to structural differences
between genes of studied ESBL types and higher G–C
content in CTX-M type genes, hybridization temperature
was increased to 47°C instead of that chosen earlier for
gene typing of TEM type beta-lactamases to increase the
specificity of the analysis. Hybridization was carried out
for 1 h under automatic conditions in a hybridization
tube. Artificial substitutions were introduced into some
oligonucleotide sequences to lower the probability of for-
mation of dimer and other stable secondary structure ele-
ments. Molecular design of specific oligonucleotide
structures provided very high specificity of SNP determi-
nation: in 94% of oligonucleotides the fraction of unspe-
cific hybridization was below 0.4. The developed method
allows simultaneous detection of over 150 SNP, which is
much higher than the number of parameters simultane-
ously determined by other methods.
The integrated microchip was tested using 60 sam-
ples already characterized by standard phenotyping tests
for strain sensitivity to panels of antibiotics and their
combinations with inhibitors. Hybridization analysis on
the microarray revealed 93% sensitivity and 100% speci-
ficity of this method. ESBLs of one or several types were
found in 54 samples. For four samples phenotypically
identified resistance could not be explained by ESBL pro-
duction. Successful identification of different gene type
mixtures (like TEM-1 and SHV-12; TEM-1, SHV-1, and
CTX-M-15) and mixture of two genes belonging to the
same gene type (like CTX-M-15 and CTX-M-14b; SHV-
1 and SHV-14) can be considered as advantages of the
developed method. These results were confirmed by
sequencing. It should be noted that detection of a mixture
of two genes on a microarray is more clear and reliable,
especially for genes of the same type, whereas in the case
of sequencing detection of two chromatographic peaks
causes difficulties especially for automatic data process-
ing.
The variety of beta-lactamases and extremely rapid
spreading of known resistance determinants and emer-
gence of new determinants and new combinations of pre-
viously described resistance determinants make necessary
elaboration of adequate methods for their clinical diag-
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Fig. 7. Relative specificity of point mutation detection in CTX-M type beta-lactamase genes by hybridization analysis on microarrays with flu-
orescence and colorimetric detection. Black columns: Cy3 DNA label, hybridization conditions 45°C, 1 h; white columns: Cy3 DNA label,
hybridization conditions 47°C, 1 h; hatched columns: biotin label, hybridization conditions 45°C, 2 h.
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nostics for choosing the correct course of therapy and
monitoring of spreading of infectious diseases.
Molecular-biological methods of gene structure analysis
are indispensable for solution of these problems. Amplifi-
cation and hybridization technologies have already pro-
vided a qualitatively new level of diagnosis of many infec-
tious and genetic diseases.
Antibiotic resistance of infectious pathogens was test-
ed at the “micro” level when resistance is determined in a
single clinic or in a separate group of patients, as well as at
“macro” level in inter-center, national, and international
studies when hundreds, thousands, and tens of thousands
of pathogen strains collected in different clinics are ana-
lyzed. For large-scale investigations it is desirable to have
methods allowing detection of numerous parameters in
the same reaction that are characterized by sufficient sen-
sitivity and specificity along with high productivity.
Broad introduction of sequencing for these aims is
difficult due to complication and laboriousness of the
method, the necessity of specialized expensive equip-
ment, and to rather high cost of analysis. Multiparametric
analysis on microarrays seems to be a convenient alterna-
tive to sequencing. Multiparametric determination of
genes and mutations in them by hybridization analysis on
microarrays has great potential for use in investigation of
molecular mechanisms of infection resistance and
spreading.
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German Federal Ministry of Education and Science
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